Key Takeaways Semaglutide belongs to the GLP-1 receptor agonist category that aims to mimic the naturally occurring GLP-1 hormone in the body to address type 2 diabetes and chronic weight management
Oral Wegovy seems even slightly more effective at weight loss, as shown in OASIS 4, where participants lost 13.6% of their body weight: Oral semaglutide has existed for years (branded as Rybelsus, and sold at lower doses that dont cause much weight loss) but now oral Wegovy at a higher dose has earned its place as an additional weight loss option
Rather than becoming overly focused on exact numbers, many people benefit from aiming to include a meaningful source of protein at each meal
The doctors prescribing GLP-1s often dont have the time to address all the nuances
Additionally, because the oral form has a longer shelf life, it may offer logistical advantages for certain prescribing patterns, Ali explained
This may be linked to improved cellular function and reduced metabolic stress